BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37565253)

  • 21. Multi-Vitamin B Supplementation Reverses Hypoxia-Induced Tau Hyperphosphorylation and Improves Memory Function in Adult Mice.
    Yu L; Chen Y; Wang W; Xiao Z; Hong Y
    J Alzheimers Dis; 2016 Aug; 54(1):297-306. PubMed ID: 27497480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ezrin Expression is Increased During Disease Progression in a Tauopathy Mouse Model and Alzheimer's Disease.
    Vega IE; Umstead A; Wygant CM; Beck JS; Counts SE
    Curr Alzheimer Res; 2018; 15(12):1086-1095. PubMed ID: 30101710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein phosphatase 2A methyltransferase links homocysteine metabolism with tau and amyloid precursor protein regulation.
    Sontag E; Nunbhakdi-Craig V; Sontag JM; Diaz-Arrastia R; Ogris E; Dayal S; Lentz SR; Arning E; Bottiglieri T
    J Neurosci; 2007 Mar; 27(11):2751-9. PubMed ID: 17360897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A.
    Zhou XW; Gustafsson JA; Tanila H; Bjorkdahl C; Liu R; Winblad B; Pei JJ
    Neurobiol Dis; 2008 Sep; 31(3):386-94. PubMed ID: 18586097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tetrandrine ameliorates cognitive deficits and mitigates tau aggregation in cell and animal models of tauopathies.
    Tong BC; Huang AS; Wu AJ; Iyaswamy A; Ho OK; Kong AH; Sreenivasmurthy SG; Zhu Z; Su C; Liu J; Song J; Li M; Cheung KH
    J Biomed Sci; 2022 Oct; 29(1):85. PubMed ID: 36273169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy.
    Hansen HH; Barkholt P; Fabricius K; Jelsing J; Terwel D; Pyke C; Knudsen LB; Vrang N
    Brain Res; 2016 Mar; 1634():158-170. PubMed ID: 26746341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyk2 is a Novel Tau Tyrosine Kinase that is Regulated by the Tyrosine Kinase Fyn.
    Li C; Götz J
    J Alzheimers Dis; 2018; 64(1):205-221. PubMed ID: 29782321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The toxin MPTP generates similar cognitive and locomotor deficits in hTau and tau knock-out mice.
    Gratuze M; Josset N; Petry FR; Pflieger M; Eyoum Jong L; Truchetti G; Poitras I; Julien J; Bezeau F; Morin F; Samadi P; Cicchetti F; Bretzner F; Planel E
    Brain Res; 2019 May; 1711():106-114. PubMed ID: 30641037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leucine carboxyl methyltransferase 1 (LCMT1)-dependent methylation regulates the association of protein phosphatase 2A and Tau protein with plasma membrane microdomains in neuroblastoma cells.
    Sontag JM; Nunbhakdi-Craig V; Sontag E
    J Biol Chem; 2013 Sep; 288(38):27396-27405. PubMed ID: 23943618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization.
    Yadikar H; Torres I; Aiello G; Kurup M; Yang Z; Lin F; Kobeissy F; Yost R; Wang KK
    PLoS One; 2020; 15(7):e0224952. PubMed ID: 32692785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy.
    Soler H; Dorca-Arévalo J; González M; Rubio SE; Ávila J; Soriano E; Pascual M
    Neurobiol Aging; 2017 Jan; 49():40-51. PubMed ID: 27743524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rho-kinase ROCK inhibitors reduce oligomeric tau protein.
    Hamano T; Shirafuji N; Yen SH; Yoshida H; Kanaan NM; Hayashi K; Ikawa M; Yamamura O; Fujita Y; Kuriyama M; Nakamoto Y
    Neurobiol Aging; 2020 May; 89():41-54. PubMed ID: 31982202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia.
    Seo J; Kritskiy O; Watson LA; Barker SJ; Dey D; Raja WK; Lin YT; Ko T; Cho S; Penney J; Silva MC; Sheridan SD; Lucente D; Gusella JF; Dickerson BC; Haggarty SJ; Tsai LH
    J Neurosci; 2017 Oct; 37(41):9917-9924. PubMed ID: 28912154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The protein phosphatase PP2A/Bα binds to the microtubule-associated proteins Tau and MAP2 at a motif also recognized by the kinase Fyn: implications for tauopathies.
    Sontag JM; Nunbhakdi-Craig V; White CL; Halpain S; Sontag E
    J Biol Chem; 2012 Apr; 287(18):14984-93. PubMed ID: 22403409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy.
    DeVos SL; Miller RL; Schoch KM; Holmes BB; Kebodeaux CS; Wegener AJ; Chen G; Shen T; Tran H; Nichols B; Zanardi TA; Kordasiewicz HB; Swayze EE; Bennett CF; Diamond MI; Miller TM
    Sci Transl Med; 2017 Jan; 9(374):. PubMed ID: 28123067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabidiol (CBD) treatment improves spatial memory in 14-month-old female TAU58/2 transgenic mice.
    Kreilaus F; Przybyla M; Ittner L; Karl T
    Behav Brain Res; 2022 May; 425():113812. PubMed ID: 35202719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer's disease models.
    Zhang H; Wang X; Xu P; Ji X; Chi T; Liu P; Zou L
    J Physiol Sci; 2020 Jun; 70(1):29. PubMed ID: 32517647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer's disease.
    Chiasseu M; Alarcon-Martinez L; Belforte N; Quintero H; Dotigny F; Destroismaisons L; Vande Velde C; Panayi F; Louis C; Di Polo A
    Mol Neurodegener; 2017 Aug; 12(1):58. PubMed ID: 28774322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling.
    Kickstein E; Krauss S; Thornhill P; Rutschow D; Zeller R; Sharkey J; Williamson R; Fuchs M; Köhler A; Glossmann H; Schneider R; Sutherland C; Schweiger S
    Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21830-5. PubMed ID: 21098287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuronal loss and inflammation preceding fibrillary tau pathology in a rat model with early human-like tauopathy.
    Emmerson JT; Malcolm JC; Do Carmo S; Nguyen P; Breuillaud L; Martinez-Trujillo JC; Cuello AC
    Neurobiol Dis; 2023 Oct; 187():106317. PubMed ID: 37802153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.